Health News

News > Health News

RSS Feed

DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with metastatic triple-negative breast cancer for whom immunotherapy was not an option

4:00 AM on Sunday, October 19

DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02

11:30 PM on Saturday, October 18

KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Disease Progression or Death Versus Chemotherapy With or Without Bevacizumab in Certain Patients With Platinum-Resistant Recurrent Ovarian Cancer

7:35 AM on Saturday, October 18

ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease recurrence or death by 53% vs. T-DM1 in patients with high-risk HER2-positive early breast cancer following neoadjuvant therapy in DESTINY-Breast05 Phase III trial

7:35 AM on Saturday, October 18

KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 60% and Risk of Death by 50% for Certain Patients with Muscle-Invasive Bladder Cancer When Given Before and After Surgery

7:30 AM on Saturday, October 18

ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a pathologic complete response in 67% of patients with high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11 Phase III trial

7:30 AM on Saturday, October 18

ENHERTU® Reduced the Risk of Disease Recurrence or Death by 53% Versus T-DM1 in Patients with High-Risk HER2 Positive Early Breast Cancer Following Neoadjuvant Therapy in DESTINY-Breast05 Phase 3 Trial

7:30 AM on Saturday, October 18

Nurse Rod Salaysay plays guitar for patient Richard Hoang in the recovery unit of UC San Diego Health in San Diego, Calif., on Sept. 30, 2025. (AP Photo/Javier Arciga)

Music could help ease pain from surgery or illness. Scientists are listening

6:04 AM on Saturday, October 18

Hospitals and doctors' offices are inviting singers and musicians to help patients manage their pain, as music's ability to reduce pain is gaining attention

Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025

4:00 AM on Saturday, October 18

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen

3:00 AM on Saturday, October 18

First ... 38 39 40 41 42 ... Last

Salem News Channel Today

Sponsored Links

On Air & Up Next

  • The Hugh Hewitt Show
    12:00PM - 3:00PM
     
    Hugh Hewitt is one of the nation’s leading bloggers and a genuine media   >>
     
  • The Larry Elder Show
    3:00PM - 6:00PM
     
    Larry Elder personifies the phrase “We’ve Got a Country to Save” The “Sage from   >>
     
  • The Inland Empire Answer
    6:00PM - 7:00PM
     
    Join Host Jennifer Horn for News and commentary that hits the bullseye for   >>
     
  • SEKULOW
    7:00PM - 8:00PM
     
    Jay Sekulow is a passionate advocate for protecting religious and   >>
     
  • The Mike Gallagher Show
    8:00PM - 11:00PM
     
    Happier Days: White House Marks Anniversary of Trump’s Triumph U.S. to Reduce   >>
     

See the Full Program Guide